States across India are imposing bans or suspending the sale of the cough syrup Coldrif amid alarming reports linking it to child deaths in Madhya Pradesh, Rajasthan and beyond.
The controversy began after several children in Chhindwara (MP) developed acute kidney failure and died. Authorities found that samples of Coldrif—manufactured by Sresan Pharmaceuticals, Tamil Nadu—contained diethylene glycol (DEG) in concentrations far exceeding safe limits. In laboratory tests, the syrup was declared “Not of Standard Quality.”
In response, Madhya Pradesh immediately banned the sale of Coldrif and began seizure of existing stocks. Tamil Nadu had already suspended its sales from October 1. Kerala too acted as a precautionary measure, halting distribution despite the possibly affected batch not being marketed there.
Central government’s decision to withdraw a special GST
The Delhi Police have registered a case under multiple sections
It will feature a new international subsea gateway
Prime Minister Narendra Modi hosted Mongolian President
The incident occurred near the university auditorium
Prime Minister underlined the significance of deepening cooperation
He manipulated tender conditions and conspired
The government has issued a stern directive to airlines
He will hold talks with Prime Minister Modi
The relaxation would be within fixed slots
Delhi court has rejected a plea by Union Minister
The University of Oxford retains the number one position
The syrup was found to contain harmful substances
.avif)
Kishore was promptly restrained by security personnel during the incident
Calls for a nationwide ban
Kulman Ghising, credited with ending Nepal’s power cuts and reforming the energy...
NATO forces successfully intercepted a large-scale overnight drone raid launched...
Priya Sachdev’s lawyer has questioned Karisma Kapoor’s absence from Sunjay Kapur...
Qatar has strongly condemned what it describes as a “cowardly criminal assault”...
Karnataka Congress MLA Satish Krishna Sail has been arrested by the Enforcement...
